187 related articles for article (PubMed ID: 34497601)
21. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
Cote CK; Welkos SL
Toxins (Basel); 2015 Aug; 7(8):3167-78. PubMed ID: 26287244
[TBL] [Abstract][Full Text] [Related]
22. Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.
Gu C; Jenkins SA; Xue Q; Xu Y
J Immunol; 2012 May; 188(9):4421-31. PubMed ID: 22442442
[TBL] [Abstract][Full Text] [Related]
23. Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores.
Pickering AK; Merkel TJ
Infect Immun; 2004 May; 72(5):3069-72. PubMed ID: 15102824
[TBL] [Abstract][Full Text] [Related]
24. Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages.
Premanandan C; Storozuk CA; Clay CD; Lairmore MD; Schlesinger LS; Phipps AJ
Microb Pathog; 2009 Jun; 46(6):306-14. PubMed ID: 19328844
[TBL] [Abstract][Full Text] [Related]
25. Bacillus anthracis factors for phagosomal escape.
Tonello F; Zornetta I
Toxins (Basel); 2012 Jul; 4(7):536-53. PubMed ID: 22852067
[TBL] [Abstract][Full Text] [Related]
26. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores.
Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA
PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462
[TBL] [Abstract][Full Text] [Related]
27. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.
Cote CK; Van Rooijen N; Welkos SL
Infect Immun; 2006 Jan; 74(1):469-80. PubMed ID: 16369003
[TBL] [Abstract][Full Text] [Related]
28. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis.
Brittingham KC; Ruthel G; Panchal RG; Fuller CL; Ribot WJ; Hoover TA; Young HA; Anderson AO; Bavari S
J Immunol; 2005 May; 174(9):5545-52. PubMed ID: 15843553
[TBL] [Abstract][Full Text] [Related]
30. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
Welkos S; Friedlander A; Weeks S; Little S; Mendelson I
J Med Microbiol; 2002 Oct; 51(10):821-831. PubMed ID: 12435060
[TBL] [Abstract][Full Text] [Related]
31. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.
Cote CK; Bozue J; Twenhafel N; Welkos SL
J Med Microbiol; 2009 Jun; 58(Pt 6):816-825. PubMed ID: 19429760
[TBL] [Abstract][Full Text] [Related]
32. The germination-specific lytic enzymes SleB, CwlJ1, and CwlJ2 each contribute to Bacillus anthracis spore germination and virulence.
Giebel JD; Carr KA; Anderson EC; Hanna PC
J Bacteriol; 2009 Sep; 191(18):5569-76. PubMed ID: 19581364
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
[TBL] [Abstract][Full Text] [Related]
34. Convergent evolution of diverse Bacillus anthracis outbreak strains toward altered surface oligosaccharides that modulate anthrax pathogenesis.
Norris MH; Kirpich A; Bluhm AP; Zincke D; Hadfield T; Ponciano JM; Blackburn JK
PLoS Biol; 2020 Dec; 18(12):e3001052. PubMed ID: 33370274
[TBL] [Abstract][Full Text] [Related]
35. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.
Booth JL; Duggan ES; Patel VI; Langer M; Wu W; Braun A; Coggeshall KM; Metcalf JP
Microbes Infect; 2016 Oct; 18(10):615-626. PubMed ID: 27320392
[TBL] [Abstract][Full Text] [Related]
36. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA
PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994
[TBL] [Abstract][Full Text] [Related]
37. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells.
Shetron-Rama LM; Herring-Palmer AC; Huffnagle GB; Hanna P
Microb Pathog; 2010; 49(1-2):38-46. PubMed ID: 20188814
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.
Majumder S; Das S; Kingston J; Shivakiran MS; Batra HV; Somani VK; Bhatnagar R
Med Microbiol Immunol; 2020 Apr; 209(2):125-137. PubMed ID: 31811379
[TBL] [Abstract][Full Text] [Related]
39. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
[TBL] [Abstract][Full Text] [Related]
40. Dissemination bottleneck in a murine model of inhalational anthrax.
Plaut RD; Kelly VK; Lee GM; Stibitz S; Merkel TJ
Infect Immun; 2012 Sep; 80(9):3189-93. PubMed ID: 22753373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
